STEPHANIE MAAR: Open Payments
NPI 1124540729 · FEDERAL WAY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $77 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $150 |
| ABBVIE INC. | 7 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $14 |
Products named: Livdelzi, SKYRIZI, ENTYVIO, RINVOQ, ZENPEP, TREMFYA, EOHILIA, VOQUEZNA.
Industry payments across WA — which companies pay providers there.
